Physician profile
Deborah D Watson
NPI 1134145931
$661.20
in general payments reported to CMS, 2019-2025
10 companies · $78.10 in 2025
The $78.10 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $82.27 · 2021: $102 · 2022: $35.16 · 2023: $34.63 · 2025: $78.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $112.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $280.47 | 2019-2021 | |
| Pfizer INC. | $122.14 | 2019-2023 | |
| Tris Pharma INC | $78.13 | 2019-2022 | |
| Glaxosmithkline, LLC. | $45.93 | 2019-2023 | Pediarix, Bexsero |
| Merck Sharp & Dohme LLC | $29.06 | 2019-2025 | M-M-R II, Enflonsia, Rotateq |
| Seqirus USA INC | $28.14 | 2025 | Flucelvax |
| Takeda Pharmaceuticals U.S.A., INC. | $25.38 | 2020 | |
| Mylan Pharmaceuticals INC. | $18.19 | 2019 | |
| Cranial Technologies, INC | $16.97 | 2025 | Doc Band |
| Kowa Pharmaceuticals America, INC. | $16.79 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Watson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.